BACKGROUND: Evidence about the beneficial effects of statins on reducing infections is accumulating. Identifying ways to reduce infection risk in patients with cirrhosis is important because of increased mortality risk and costs associated with infections. AIM: To estimate the extent to which statin use prolongs time to infection among patients with cirrhosis. METHODS: We identified Veterans with cirrhosis, but without decompensation (n = 19,379) using US Veterans Health Administration data from 2001 to 2009. New users of statins were identified and propensity matched to non-users and users of other cholesterol-lowering medications (1:1 matching). The cohort was followed up for hospitalisations with infections. Cox regression models with ti...
Many studies have elucidated the protective associations of statin use with liver cancer or mortalit...
Objectives: To assess whether prior statin use protects against the development of Clostridium diffi...
AbstractCurrent evidence suggests that statins may improve outcome in infectious diseases. This stud...
Background Recent studies have shown benefits of statins in patients with liver cirrhosis. However, ...
Background & Aims: Several animal studies have shown that statins can inhibit the progression of cir...
BackgroundRecent studies have shown benefits of statins in patients with liver cirrhosis. However, i...
Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea and places ...
OBJECTIVES: The protective effect of statins in cirrhosis and its decompensation in chronic hepatiti...
Background: Liver cirrhosis causes over one million deaths annually worldwide, but its prognosis var...
Background & aimsStatins have been variably shown to decrease risk and complications of chronic ...
Statins exert cholesterol-independent beneficial effects, including immunomodulatory effects. In thi...
Approximately 170 million people in the world and 3.9 million people in the United States are infect...
Adjusted hazard ratios of different statins for 30-day mortalities of cirrhotic patients with bacter...
[[abstract]]Background: Alcohol-related liver disease (ALD) is the most common cause of liver diseas...
BACKGROUND: An association between exposure to statin drugs and favourable treatment outcomes for va...
Many studies have elucidated the protective associations of statin use with liver cancer or mortalit...
Objectives: To assess whether prior statin use protects against the development of Clostridium diffi...
AbstractCurrent evidence suggests that statins may improve outcome in infectious diseases. This stud...
Background Recent studies have shown benefits of statins in patients with liver cirrhosis. However, ...
Background & Aims: Several animal studies have shown that statins can inhibit the progression of cir...
BackgroundRecent studies have shown benefits of statins in patients with liver cirrhosis. However, i...
Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea and places ...
OBJECTIVES: The protective effect of statins in cirrhosis and its decompensation in chronic hepatiti...
Background: Liver cirrhosis causes over one million deaths annually worldwide, but its prognosis var...
Background & aimsStatins have been variably shown to decrease risk and complications of chronic ...
Statins exert cholesterol-independent beneficial effects, including immunomodulatory effects. In thi...
Approximately 170 million people in the world and 3.9 million people in the United States are infect...
Adjusted hazard ratios of different statins for 30-day mortalities of cirrhotic patients with bacter...
[[abstract]]Background: Alcohol-related liver disease (ALD) is the most common cause of liver diseas...
BACKGROUND: An association between exposure to statin drugs and favourable treatment outcomes for va...
Many studies have elucidated the protective associations of statin use with liver cancer or mortalit...
Objectives: To assess whether prior statin use protects against the development of Clostridium diffi...
AbstractCurrent evidence suggests that statins may improve outcome in infectious diseases. This stud...